Knight Therapeutics Inc. (TSX: GUD)

Knight Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	571	541	584	630	696	1,028
Market Cap Growth	7.71%	-7.35%	-7.29%	-9.50%	-32.33%	-6.41%
Enterprise Value	468	455	466	510	337	321
Last Close Price	5.64	5.19	5.18	5.30	5.35	7.58
PE Ratio	-	-32.44	-19.91	42.09	16.76	75.80
PS Ratio	1.72	1.65	1.99	2.59	3.49	21.66
PB Ratio	0.75	0.72	0.71	0.75	0.78	1.12
P/FCF Ratio	9.41	15.45	13.86	15.44	-39.57	229.12
P/OCF Ratio	9.13	15.05	12.97	14.11	-57.00	223.69
EV/Sales Ratio	1.38	1.39	1.59	2.10	1.69	6.75
EV/EBITDA Ratio	8.06	8.55	11.38	15.73	113.34	-354.58
EV/EBIT Ratio	58.45	71.47	-27.33	-39.78	-12.81	-69.11
EV/FCF Ratio	7.71	13.01	11.07	12.52	-19.17	71.44
Debt / Equity Ratio	0.08	0.09	0.09	0.05	0.06	0.07
Debt / EBITDA Ratio	1.00	1.24	1.73	1.18	9.99	-
Debt / FCF Ratio	0.96	1.97	1.84	1.00	-3.20	13.86
Asset Turnover	0.34	0.33	0.29	0.24	0.17	0.04
Inventory Turnover	1.72	1.90	1.89	1.99	1.85	0.57
Quick Ratio	2.38	2.35	2.08	2.16	4.28	1.50
Current Ratio	3.41	3.20	2.80	2.90	4.84	1.77
Return on Equity (ROE)	-2.70%	-2.14%	-3.58%	1.81%	3.53%	1.85%
Return on Assets (ROA)	0.51%	0.40%	-1.04%	-0.79%	-1.40%	-0.25%
Return on Capital (ROIC)	0.59%	0.46%	-1.19%	-0.88%	-1.71%	-0.29%
Earnings Yield	-3.65%	-3.11%	-5.12%	2.49%	6.05%	1.41%
FCF Yield	10.62%	6.47%	7.22%	6.48%	-2.53%	0.44%
Buyback Yield / Dilution	7.80%	6.46%	7.73%	5.65%	5.82%	2.19%
Total Shareholder Return	7.80%	6.46%	7.73%	5.65%	5.82%	2.19%

Source: S&P Capital IQ. Standard template. Financial Sources.